ClinicalTrials.gov
public full text
Public Domain
Kuvan®'s Effect on the Cognition of Children With Phenylketonuria
The study is a single-cohort, interventional, open-label trial to evaluate long-term neurocognitive (NC) outcomes in children aged 4 to 5 years with phenylketonuria (PKU) treated with Kuvan® and Phenylalanine-restricted diet over a period of 7 years.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Tetrahydrobiopterin Treatment in Children With Idiopathic Cognitive Developmental Disorders#873317
- Retrospective Evaluation of POCD Data of Studies From KAI, Charité - Universitätsmedizin Berlin#1322502
- Effects of Psilocybin on Electrophysiology and the Dynamic Content of Thought#1096120
- Intracerebral Gene Therapy for Children With Early Onset Forms of Metachromatic Leukodystrophy#1125568
- Exploratory Trial in Healthy Adults With Mild Cognitive Impairment,16-week Intervention With Mitocholine™#1281579
Record · ID 1307728
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive